requirement of the European Commission, reporting is not standardised or
mandatory. Here we review the current literature, guidelines on diagnosis and
treatment and conclude by highlighting a number of areas where further research
would increase our understanding.”Karpin, G. W., Morris, D. M., Ngo, M. T., et al. (2015). Transition metal diamine
complexes with antimicrobial activity against staphylococcus aureus and methicillin-
resistant S. aureus (MRSA). Med. Chem. Commun. 451. pg. 990-94.
http://pubs.rsc.org/en/content/articlelanding/2015/md/c5md00228a#!divAbstract
- “Emerging infectious diseases (EIDs) are a significant burden on global
economies and public health” - “We find that 54.3% of EID events are caused by bacteria or rickettsia, reflecting
a large number of drug-resistant microbes in our database.” - “Global resources to counter disease emergence are poorly allocated, with the
majority of the scientific and surveillance effort focused on countries from where
the next important EID is least likely to originate.”
Katz, J. (2004). Hand washing and hand disinfection: More than your mother taught
you. Anesthesiology Clinics of North America. 22(3). pg. 115-28.
http://www.sciencedirect.com/science/article/pii/S0889853704000276
- Which article is the quote below from? Jones or Katz? Note it is repeated.
- “Clostridium difficile infection is the leading cause of diarrhoea in the
industrialised world. First identified in 1935, our knowledge about the clonal
population structure, toxins and PCR ribotypes is still increasing. New PCR
ribotypes and sequence types are frequently added. In the last decade
hypervirulent strains have emerged and been associated with increased severity
of disease, high recurrence and significant mortality. Although previously a
primarily hospital- or health-care acquired infection, since the 1990's C. difficile
infections that are community-acquired have been increasingly reported. Risk
factors include hospitalisation, advancing age and prior antibiotic use. The
ubiquitous presence of C. difficile in the environment and asymptomatic
intestinal colonisation may be important reservoirs for infection and the changing
epidemiology of C. difficile infection. Although surveillance in Europe is now a
requirement of the European Commission, reporting is not standardised or
mandatory. Here we review the current literature, guidelines on diagnosis and
treatment and conclude by highlighting a number of areas where further research
would increase our understanding.”